Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Smoking cessation study

This article was originally published in The Tan Sheet

Executive Summary

Nicotine replacement therapy with OTC gum or patch "at least" as good as Rx treatment, study conducted by Saul Shiffman, MD, University of Pittsburgh, et al., concludes. Published in May issue of Addiction, research involved contrasting data from parallel, independent studies assessing usage, outcomes from GlaxoSmithKline's Nicorette gum and NicoDerm CQ patch in simulated OTC and "real world" Rx settings. Abstinence after six weeks and six months of treatment was compared. The OTC evaluation enrolled 5,348 smokers, while Rx use information was obtained from 933 smokers who had filed prescriptions for treatments...

Related Content

NRT Outcomes In California Study Counter “Authoritative” Data – GSK





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts